Showing results (2041-2050 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|December 1, 2020
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trialCesare Perotti, Fausto Baldanti, Raffaele Bruno, et al.Haematologica|May 27, 2021
Towards manufactured red blood cells for the treatment of inherited anemiaStephanie Pellegrin, Charlotte E Severn, Ashley M ToyeHaematologica|June 16, 2022
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatmentJames B Bussel, Christine A GarciaHaematologica|June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.Haematologica|January 12, 2023
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS studyFrancesca R Mauro, Irene Della Starza, Monica Messina, et al.Haematologica|December 22, 2022
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimenPaola Simeone, Rossella Liani, Romina Tripaldi, et al.Haematologica|June 23, 2022
STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatmentJordy C G Van der Zwet, Valentina Cordo', Jessica G C A M Buijs-Gladdines, et al.Haematologica|July 14, 2022
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial dataMegan Othus, Guillermo Garcia-Manero, John E Godwin, et al.Haematologica|May 26, 2019
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Elisa Lucchini, Francesco Zaja, James BusselHaematologica|April 29, 2022
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantationBenedetta Rambaldi, Haesook T Kim, Yohei Arihara, et al.Pageof 816